枸橼酸托法替尼丨枸橼酸托法替布
Tofacitinib Citrate | Tasocitinib Citrate | CP-690550 Citrate
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Tofacitinib Citrate | Tasocitinib Citrate | CP-690550 Citrate
CAS540737-29-9
FormulaC16H20N6O.C6H8O7
MW504.49
Appearance White to off-white powder
Storage condition4°C, sealed storage, away from moisture and light
Security information
Product details

Tofacitinib, also known as tasocitinib, CP-690550, is a Janus kinase (JAK) inhibitor. Tofacitinib modulates the signaling pathway at the point of JAKs, preventing the phosphorylation and activation of STATs. JAK enzymes transmit cytokine signaling through pairing of JAKs (e.g., JAK1/JAK3, JAK1/JAK2, JAK1/TyK2, JAK2/JAK2). Tofacitinib inhibited the in vitro activities of JAK1/JAK2, JAK1/JAK3, and JAK2/JAK2 combinations with IC50 of 406, 56, and 1377 nM, respectively.

Related
Sorry, no related items
History
(E)-4-Hydroxytamoxifen; (E)-Afimoxifene
Tofacitinib Citrate | Tasocitinib Citrate | CP-690550 Citrate
Zongertinib (Synonyms: BI 1810631;BI 764532)
Fmoc-NH-PEG4-alcohol
GNE-9815
Afuresertib-F HCl | GSK2110183-analog 1 HCl |
(R)-Cyclopropyl(4-fluorophenyl)methanamine hydrochloride
Fenretinide (Synonyms: 4-HPR; 维甲酰酚胺; 芬维A胺;酚维A胺)